Prospective Study
Copyright ©The Author(s) 2017.
World J Hepatol. Jul 18, 2017; 9(20): 896-904
Published online Jul 18, 2017. doi: 10.4254/wjh.v9.i20.896
Table 1 Comparison between patients who developed post-living-donor liver transplantation single episode and those who developed repeated episodes of infection regarding pre-operative parameters n (%)
Single episode of infection (n = 21)Repeated episodes of infection (n = 12)P value
Recipient's age (yr, mean ± SD)51.2 ± 8.352.08 ± 8.70.767
Donor's age (yr, mean ± SD)26.9 ± 6.332.3 ± 6.10.021
Recipient's gender (male/female)19/212/00.523
Donor’s gender (male/female)19/210/20.610
Hepatocellular carcinoma6 (28.6)8 (66.7)0.033
History of bridging procedures14 (19.0)6 (50.0)0.114
History of SBP10 (47.6)1 (8.3)0.052
History of paracentesis11 (52.4)4 (33.3)0.290
Diabetes mellitus8 (38.1)5 (41.7)1.000
Child-Pugh class (B/C)10/115/70.741
MELD score (median, interquartile range)14 (12-16)16 (15-18)0.136
Thrombocytopenia220 (95.2)12 (100.0)1.000
Leucopenia39 (42.9)5 (41.7)0.947
Renal impairment2 (9.5)1 (8.3)1.000
High serum ferritin413 (61.9)5 (41.7)0.261
High C-reactive protein514 (66.7)11 (91.7)0.206